Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crompton & Knowles was a prominent American specialty chemical company that played a significant role in the pharmaceutical and food industries through its production of dyes, flavors, and ingredient technologies. Originally founded as a textile machinery manufacturer in the 19th century, the company pivoted to specialty chemicals, becoming a leading supplier of pharmaceutical-grade colorants and excipients. Through its Ingredient Technology Corporation subsidiary, it provided specialized chemical solutions that supported the life sciences sector. In 1999, Crompton & Knowles merged with Witco Corporation to form Crompton Corporation, which later became part of Chemtura. The business was eventually acquired by the specialty chemicals giant Lanxess in 2017. The company's legacy in the life sciences is primarily tied to its high-purity chemical additives and ingredient systems used in drug formulation and medical diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crompton and Knowles.